RecruitingNot Applicable

IL-6 and Hemogram-Derived Inflammatory Indices for Mortality Prediction in Postoperative ICU Patients

Turkey (Türkiye)42 participantsStarted 2025-12-15

Plain-language summary

This prospective observational cohort study aims to evaluate the predictive value of interleukin-6 (IL-6) levels and hemogram-derived inflammatory scores for morbidity and in-hospital mortality in postoperative patients admitted to the intensive care unit (ICU). IL-6 levels and inflammatory indices will be assessed at ICU admission and at 24 hours using data obtained from routine clinical care. Associations between these biomarkers and clinical outcomes, including mortality, morbidity, antibiotic use, and duration of mechanical ventilation, will be evaluated after adjustment for illness severity.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Postoperative patients admitted to the ICU * Availability of complete clinical and laboratory data at ICU admission and at 24 hours * Provision of informed consent by the patient or legally authorized representative Exclusion Criteria: * Age \< 18 years * Thoracic surgery patients * Cardiac surgery patients

What they're measuring

In-hospital mortality (all-cause)

Timeframe: Within 28 days of ICU admission

Postoperative morbidity

Timeframe: Within 28 days

Trial details

NCT IDNCT07460141

SponsorEzgi Günaydın

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-03-15

Contact for this trial

Ezgi Günaydın, MD

+905336834198 ezgunaydin@gmail.com

View on ClinicalTrials.gov More Postoperative Complications trials